Family summary
Historical shortage references are available across related Levothyroxine Sodium Anhydrous presentations from multiple manufacturers.
- 0 current shortage context pages.
- 4 historical shortage context pages.
- 2 manufacturers represented.
Levothyroxine Sodium Anhydrous - Drug Shortage Information
Public shortage context is available across 4 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Levothyroxine Sodium Anhydrous 100 ug / 5mL Injection 5 mL - NDC 42023-0201-01ENDO USA, Inc. | 1 Vial, Single-DoseLevothyroxine Sodium Anhydrous 200 ug / 5mL Injection 5 mL - NDC 63323-0647-10Fresenius Kabi USA, LLC | 1 Vial, Single-DoseLevothyroxine Sodium Anhydrous 500 ug / 5mL Injection 5 mL - NDC 63323-0648-10Fresenius Kabi USA, LLC | 1 Vial, Single-DoseLevothyroxine Sodium Anhydrous 100 ug / 5mL Injection 5 mL - NDC 63323-0649-07Fresenius Kabi USA, LLC | 1 Vial, Single-Dose
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|---|---|---|
| Levothyroxine Sodium Anhydrous 100 ug / 5mL Injection 5 mL NDC 42023-0201-01 | 1 Vial, Single-Dose | ENDO USA, Inc. | 42023-0201-01 | ENDO USA, Inc. | Historical shortage context |
| Levothyroxine Sodium Anhydrous 200 ug / 5mL Injection 5 mL NDC 63323-0647-10 | 1 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0647-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Levothyroxine Sodium Anhydrous 500 ug / 5mL Injection 5 mL NDC 63323-0648-10 | 1 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0648-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Levothyroxine Sodium Anhydrous 100 ug / 5mL Injection 5 mL NDC 63323-0649-07 | 1 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0649-07 | Fresenius Kabi USA, LLC | Historical shortage context |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.